After multivariate analysis, males had lower odds of NSP if they had reduced back endurance [OR: 0.66 (95% CI: 0.46 0.97)], reduced persistent control [0.42 (0.19–0.95], and increased muscle power [0.33 (0.12–0.94)], and higher odds of NSP if they had a higher basketball throw [2.47 (1.22–5.00)] and jump performance [3.47 (1.55–7.74)].
In multivariate analysis, males 1.6(1.4-1.9 1.4-1.9tes borneonatesoor mothers who had no oxen 1.2(1.0-1.3) lived in thatched houses 2.9(2.4-3.5) and a distance to a health facility 1.5(1.1-2.0) conferred the highest risk of neonatal deaths.
However, even in multivariate analysis, male sex was associated with poorer outcomes.
Like in other studies in Mozambique, in our multivariate analysis male sex was associated with high attrition rates (11).
In multivariate analysis, male circumcision demonstrated a significant association with HSV-2 (OR, 1.37; 95% CI, 1.03-1.82) but not with syphilis (OR, 1.20; 95% CI, 0.77-1.66).
In multivariate analysis, male patients were more likely than female patients to be prescribed PIMs listed in the Beers and PRISCUS criteria (table 4).
In multivariate analysis, male and heavily treated patients were also more willing to participate in cancer CTs (OR=1.17, 1.14 2.75, P=0.01: OR=1.01 2.511–2.51, P=0.04, respectively; Table 5).
After multivariate analysis, male gender, an increase in SAPS II scores, surgical patients, no decrease in SOFA scores during the first 24 hours and the interventional period of the Sepsi d'Oc study were independently associated with renal dysfunction.
In the multivariate analysis, male sex (odds ratio [OR] 1.9; 95% CI 1.0 3.7), contact with meningitis case-patients (OR 4.8; 95% CI 1.3 17.8), difficult breathing (OR 6.8; 95% CI 1.4 33.4), and itchy eyes (OR 4.4; 95% CI 1.3 14.4) remained significantly associated with cases.
In multivariate analysis, male abstainers could be differentiated from consumers by their perception of social problems stemming from khat use and the belief that khat use leads to loss of valuable work time.
In multivariate analysis, male gender (p = 0.017), advanced tumor (T3, 4a) stage (p = 0.029), and clinical lymphadenopathy (p = 0.006) were risk factors for DFS in stage I pediatric patients.
